<table cellpadding="4.8pt" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3: Effect of Coadministered Drugs on Systemic Exposures of Saxagliptin and its Active Metabolite, 5-hydroxy Saxagliptin</caption>
<col width="27%"></col>
<col width="30%"></col>
<col width="15%"></col>
<col width="15%"></col>
<col width="7%"></col>
<col width="6%"></col>
<thead>
<tr>
<th align="left" stylecode="Rrule Lrule Toprule " valign="top">
<content stylecode="bold">Coadministered Drug</content>
</th>
<th align="center" stylecode="Rrule Lrule Toprule " valign="top">
<content stylecode="bold">Dosage of</content>
<br/>
<content stylecode="bold">Coadministered Drug</content>
<footnote id="_Ref420591183">Single dose unless otherwise noted</footnote>
</th>
<th align="center" stylecode="Rrule Lrule Toprule " valign="top">
<content stylecode="bold">Dosage of</content>
<br/>
<content stylecode="bold">Saxagliptin</content>
<footnoteref idref="_Ref420591183"></footnoteref>
</th>
<th align="center" colspan="3" stylecode="Rrule Lrule Toprule " valign="top">
<content stylecode="bold">Geometric Mean Ratio</content>
<br/>
<content stylecode="bold">(ratio with/without coadministered drug)</content>
<br/>
<content stylecode="bold">No Effect = 1.00</content>
</th>
</tr>
<tr>
<th align="left" stylecode="Rrule Lrule Botrule " valign="top">
<content stylecode="bold"> </content>
</th>
<th align="left" stylecode="Rrule Lrule Botrule " valign="top">
<content stylecode="bold"> </content>
</th>
<th align="left" stylecode="Rrule Lrule Botrule " valign="top">
<content stylecode="bold"> </content>
</th>
<th align="left" stylecode="Rrule Lrule Botrule " valign="top">
<content stylecode="bold"> </content>
</th>
<th align="center" stylecode="Rrule Lrule Botrule " valign="top">
<content stylecode="bold">AUC</content>
<footnote id="_Ref420591233">AUC = AUC(INF) for drugs given as single dose and AUC = AUC(TAU) for drugs given in multiple doses</footnote>
</th>
<th align="center" stylecode="Rrule Lrule Botrule " valign="top">
<content stylecode="bold">C<sub>max</sub>
</content>
</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="6" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>
<content stylecode="bold">No dosing adjustments required for the following:</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Metformin</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>1000 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>100 mg</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>saxagliptin<br/>5-hydroxy saxagliptin</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>0.98<br/>0.99</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>0.79<br/>0.88</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Glyburide</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>5 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>10 mg</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>saxagliptin<br/>5-hydroxy saxagliptin</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>0.98<br/>ND</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>1.08<br/>ND</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Pioglitazone<footnote id="_Ref420591247">Results exclude one subject</footnote>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>45 mg QD for 10 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>10 mg QD for 5 days</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>saxagliptin<br/>5-hydroxy saxagliptin</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>1.11<br/>ND</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>1.11<br/>ND</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Digoxin</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>0.25 mg q6h first day followed by q12h second day followed by QD for<br/>5 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>10 mg QD for 7 days</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>saxagliptin<br/>5-hydroxy saxagliptin</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>1.05<br/>1.06</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>0.99<br/>1.02</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Simvastatin</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>40 mg QD for 8 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>10 mg QD for 4 days</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>saxagliptin<br/>5-hydroxy saxagliptin</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>1.12<br/>1.02</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>1.21<br/>1.08</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Diltiazem</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>360 mg LA QD for 9 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>10 mg</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>saxagliptin<br/>5-hydroxy saxagliptin</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>2.09<br/>0.66</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>1.63<br/>0.57</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Rifampin<footnote id="_Ref420591327">The plasma dipeptidyl peptidase-4 (DPP4) activity inhibition over a 24-hour dose interval was not affected by rifampin</footnote>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>600 mg QD for 6 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>5 mg</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>saxagliptin<br/>5-hydroxy saxagliptin</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>0.24<br/>1.03</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>0.47<br/>1.39</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Omeprazole</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>40 mg QD for 5 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>10 mg</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>saxagliptin<br/>5-hydroxy saxagliptin</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>1.13<br/>ND</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>0.98<br/>ND</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Aluminum hydroxide + magnesium hydroxide + simethicone</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>aluminum hydroxide:<br/>2400 mg<br/>magnesium hydroxide:<br/>2400 mg<br/>simethicone: 240 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>10 mg</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>saxagliptin<br/>5-hydroxy saxagliptin</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>0.97<br/>ND</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>0.74<br/>ND</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Famotidine</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>40 mg</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>10 mg</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>saxagliptin<br/>5-hydroxy saxagliptin</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>1.03<br/>ND</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>1.14<br/>ND</paragraph>
</td>
</tr>
<tr>
<td colspan="6" stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">Limit ONGLYZA dose to 2.5 mg once daily when coadministered with strong CYP3A4/5 inhibitors [<content stylecode="italics">see  <linkhtml href="#_Refs7.1">Drug Interactions (7.1)</linkhtml> and  <linkhtml href="#s2.3">Dosage and Administration (2.3)</linkhtml>
</content>]:</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Ketoconazole</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>200 mg BID for 9 days</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>100 mg</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>saxagliptin<br/>5-hydroxy saxagliptin</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>2.45<br/>0.12</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>1.62<br/>0.05</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule ">
<paragraph>Ketoconazole</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule ">
<paragraph>200 mg BID for 7 days</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule ">
<paragraph>20 mg</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule ">
<paragraph>saxagliptin<br/>5-hydroxy saxagliptin</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule ">
<paragraph>3.67<br/>ND</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule ">
<paragraph>2.44<br/>ND</paragraph>
</td>
</tr>
</tbody>
</table>